Form 13D/A PROVECTUS BIOPHARMACEUTICALS For: 22 July

Form 13D/A PROVECTUS BIOPHARMACEUTICALS For: 22 July

Form 13D/A PROVECTUS BIOPHARMACEUTICALS For: 22 July
Vitalik Buterin says AI’s main risk is lost human control and supports clear triggers for possible development limits. Ethereum co-founder Vitalik Buterin has addressed the growing dispute over advanced artificial intelligence. His concerns go beyond job losses, misinformation, and changes across global markets. Instead, Buterin focused on the possible loss of human control over powerful…
The hardware wallet market has seen a quiet revolution over the past few years. Even though traditional USB-style devices like Ledger and Trezor still dominate the conversation, a new category of card-shaped cold wallets has emerged. These devices look like credit cards, fit in your wallet, and use NFC to sign transactions. No cables, no…
JCB is advancing its stablecoin strategy by assessing USDC for cross-border transfers and merchant payments across Japan. Stablecoins continue to attract interest from major payment companies looking for faster and lower-cost transactions. Japan has become one of the key markets testing blockchain-based payment systems for everyday use. JCB has now taken another step in that…
Vet argues that reserve requirements serve as an important defense against spam attacks and excessive network resource usage. An XRPL validator has said that he will not vote for another reduction in its account reserves, sparking a community debate over whether lower costs would help adoption or weaken network protections. The dispute has split…
Earnings call transcript: Devyser Q2 2026 revenue misses as stock rises 5.2%